What are the treatment options for hemiplegic migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hemiplegic Migraine

Critical Contraindication

Triptans and ergot-containing medications are absolutely contraindicated in hemiplegic migraine and should never be used. 1

Acute Treatment Approach

First-Line Acute Therapy

  • NSAIDs are the primary acute treatment option, including acetaminophen (though less effective alone), ibuprofen, naproxen, or aspirin. 2, 3, 4
  • Combination analgesics containing acetaminophen, aspirin, and caffeine may be effective for mild to moderate attacks. 2, 5
  • Treatment should be initiated as early as possible during an attack for maximum efficacy. 2, 6

Adjunctive Acute Management

  • For nausea and vomiting, use metoclopramide or prochlorperazine, which also provide synergistic analgesia and improve gastric motility. 2, 5
  • Bed rest alone may be sufficient in some cases, particularly in younger patients. 2

Controversial Acute Options

  • Triptans remain highly controversial in hemiplegic migraine. While FDA labeling explicitly contraindicates their use 1, some expert opinion suggests they can be prescribed when common analgesics fail and headaches are severe. 3
  • This represents a significant divergence in the evidence, with regulatory guidance being more restrictive than some clinical practice patterns. 3
  • If triptans are considered despite contraindication warnings, this decision carries substantial medicolegal risk and requires thorough informed consent.

Medications to Avoid

  • Opioids and barbiturates should be avoided due to risk of medication overuse headache, dependency, and limited efficacy. 2, 5, 6
  • Ergot alkaloids are contraindicated. 6, 1

Prophylactic Treatment

When to Initiate Prevention

  • Consider prophylaxis when attack frequency exceeds 2 attacks per month or when severe attacks pose significant burden. 3
  • Early prophylactic treatment may prevent permanent brain damage, as severe hemiplegic migraine attacks can cause cytotoxic edema and progressive brain atrophy. 7, 8

First-Line Prophylactic Options (No Strict Order)

  • Flunarizine (5-10 mg oral once daily) - contraindicated in Parkinsonism and depression. 2, 3, 7
  • Sodium valproate (600-1,500 mg oral daily) - absolutely contraindicated in women of childbearing potential. 2, 3, 7
  • Lamotrigine - can be tried as prophylaxis. 3
  • Verapamil - calcium channel blocker option. 3
  • Acetazolamide - particularly useful in some cases. 3

Second-Line Prophylactic Options

  • Topiramate (50-100 mg oral daily) - contraindicated in pregnancy, lactation, nephrolithiasis, and glaucoma. 2, 3
  • Amitriptyline (10-100 mg oral at night) - contraindicated in age <6 years, heart failure, glaucoma, and with MAO inhibitors. 2, 3
  • Candesartan and pizotifen have less evidence but can be considered. 3

Controversial Prophylactic Options

  • Propranolol use is controversial in hemiplegic migraine, with insufficient evidence of adverse effects to definitively contraindicate beta-blockers, but caution is warranted. 3

Novel Prophylactic Therapies

  • CGRP monoclonal antibodies (e.g., galcanezumab, erenumab, fremanezumab) show promise for patients who have failed other preventive medications. 2, 5, 9
  • Case series data suggest galcanezumab reduced monthly headache days and days with motor weakness in hemiplegic migraine patients, with good tolerability. 9
  • These agents may work by blocking peripheral CGRP pathways or secondarily inhibiting cortical spreading depression. 9

Special Diagnostic Considerations

Screening for Patent Foramen Ovale (PFO)

  • Screen for PFO in patients with prolonged or intractable hemiplegic migraine, as PFO closure may significantly reduce attack frequency and prevent disabling sequelae. 8

Monitoring for Complications

  • Severe attacks can cause permanent neurological deficits, including visual impairment, cortical necrosis, and progressive cerebellar atrophy. 7, 8, 4
  • Persistent hyperperfusion during prolonged attacks may contribute to irreversible damage. 8
  • Brain atrophy may halt after cessation of severe attacks with effective prophylaxis. 7

Critical Pitfalls to Avoid

  • Never use conventional cerebral angiography in hemiplegic migraine, as this may provoke an attack. 3
  • Monitor for medication overuse headache (≥15 days/month with NSAIDs or ≥10 days/month with triptans). 5, 6
  • Distinguish hemiplegic migraine aura from TIA: aura symptoms spread gradually over ≥5 minutes and occur in succession, whereas TIA symptoms have sudden, simultaneous onset. 2
  • Consider hospitalization for long-lasting auras to manage complications and provide supportive care. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Current treatment options in neurology, 2013

Research

Diagnostic and therapeutic aspects of hemiplegic migraine.

Journal of neurology, neurosurgery, and psychiatry, 2020

Guideline

Treatment of Complex Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dexamethasone in Migraine Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Brain atrophy following hemiplegic migraine attacks.

Cephalalgia : an international journal of headache, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.